Business Description
Tissue Regenix Group PLC
ISIN : GB00BNTXR104
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.33 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | 8.49 | |||||
Interest Coverage | 0.44 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -0.86 | |||||
Beneish M-Score | -2.91 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.2 | |||||
3-Year EPS without NRI Growth Rate | 41.3 | |||||
3-Year Book Growth Rate | -6.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.41 | |||||
9-Day RSI | 38.84 | |||||
14-Day RSI | 40.32 | |||||
6-1 Month Momentum % | 2.17 | |||||
12-1 Month Momentum % | 13.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.74 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 0.62 | |||||
Days Inventory | 261.16 | |||||
Days Sales Outstanding | 49.65 | |||||
Days Payable | 82.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.53 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.48 | |||||
Operating Margin % | 1.14 | |||||
Net Margin % | -3.47 | |||||
FCF Margin % | -2.06 | |||||
ROE % | -3.64 | |||||
ROA % | -2.48 | |||||
ROIC % | 1.58 | |||||
3-Year ROIIC % | 134 | |||||
ROC (Joel Greenblatt) % | 1.05 | |||||
ROCE % | 0.54 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 67.78 | |||||
PS Ratio | 1.52 | |||||
PB Ratio | 1.63 | |||||
Price-to-Tangible-Book | 3.36 | |||||
Price-to-Operating-Cash-Flow | 108 | |||||
EV-to-EBIT | 260.63 | |||||
EV-to-Forward-EBIT | 25.12 | |||||
EV-to-EBITDA | 45.19 | |||||
EV-to-Forward-EBITDA | 16.71 | |||||
EV-to-Revenue | 1.75 | |||||
EV-to-Forward-Revenue | 1.46 | |||||
EV-to-FCF | -88.81 | |||||
Price-to-Median-PS-Value | 0.22 | |||||
Price-to-Net-Current-Asset-Value | 8.64 | |||||
Earnings Yield (Greenblatt) % | 0.38 | |||||
FCF Yield % | -1.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Tissue Regenix Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 29.354 | ||
EPS (TTM) (€) | -0.015 | ||
Beta | 0 | ||
Volatility % | 27.92 | ||
14-Day RSI | 40.32 | ||
14-Day ATR (€) | 0.026859 | ||
20-Day SMA (€) | 0.67975 | ||
12-1 Month Momentum % | 13.71 | ||
52-Week Range (€) | 0.57 - 0.875 | ||
Shares Outstanding (Mil) | 71.23 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tissue Regenix Group PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tissue Regenix Group PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Tissue Regenix Group PLC Frequently Asked Questions
What is Tissue Regenix Group PLC(FRA:LSW)'s stock price today?
When is next earnings date of Tissue Regenix Group PLC(FRA:LSW)?
Does Tissue Regenix Group PLC(FRA:LSW) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |